SEAL Hemostatic Spray PRO - for Emergency Bleeding Control
Key Features
- First & only FDA-cleared chitosan aerosol spray
- Forms clot barrier in under 5 seconds
- No wound packing required
- 2.5 oz tactical-grade canister (~80 PSI)
- Works on junctional & torso wounds
- 3-year shelf life • Made in USA
SEAL Hemostatic Spray PRO by BC3 Technologies is the first and only FDA-cleared chitosan aerosol spray for emergency bleeding control — a Rx-labeled, professional-use hemostatic that deploys as a dry-powder aerosol in under 5 seconds to form a rapid physical barrier over wounds. It is the only hemostatic on the market combining chitosan's proven muco-adhesive mechanism with aerosol delivery, validated under MIL-STD-810H and tested equivalent to Celox in FDA 510(k) clearance (K210751). Made in the USA.
Key Specifications
| Specification | Detail |
|---|---|
| Manufacturer | BC3 Technologies, Inc. (Baltimore, MD) |
| Part Number | BC3 BC30025FP |
| FDA Clearance | 510(k) K210751 — Prescription Use (Rx) |
| Active Ingredient | Medical-grade chitosan dry powder (aerosol formulation) |
| Delivery Format | Pressurized aluminum aerosol can — dry-powder spray |
| Can Size | 2.5 oz |
| Deployment Time | Can empties in under 5 seconds; barrier begins forming ~30 seconds |
| Temperature Range | –24°F to 160°F (MIL-STD-810H tested) |
| Shelf Life | 2.5 years without refrigeration |
| Sterilization | Gamma irradiation |
| Activation | Blood-activated only (not triggered by water or moisture) |
| Origin | Made in the USA |
Product Overview
SEAL Hemostatic Spray PRO represents an entirely new form factor in hemorrhage control — the world's first FDA-cleared aerosol hemostatic for emergency bleeding. BC3 Technologies, founded in Baltimore in 2018, spent approximately 12 years developing the aerosol chitosan delivery platform before achieving FDA 510(k) clearance in 2023, with a U.S. patent awarded for the formulation and delivery system in April 2025. The PRO version carries a Prescription (Rx) label intended for EMS, hospital, tactical medical, law enforcement, and fire department use.
The mechanism is chitosan-based — the same class of hemostatic agent as Celox and ChitoGauze — but delivered as a dry-powder aerosol. When SEAL contacts blood at the wound site, the chitosan particles interact with red blood cell membranes via electrostatic muco-adhesion, forming a physical barrier that rapidly seals the wound. The cold propellant in the pressurized can also acts as a mild vasoconstrictor on contact, providing an additional mechanism to slow blood flow during the initial application. The full can empties in under 5 seconds when sprayed; the hemostatic barrier begins forming within approximately 30 seconds of application.
Critically, SEAL is blood-activated only — it does not react with water, rain, or sweat. This means it maintains reliable performance in maritime operations, wet environments, rain, and situations where the casualty has been immersed. The spray has been validated under MIL-STD-810H environmental testing, maintaining reliable spray performance from –24°F to 160°F. In the rat liver model used for FDA clearance testing, SEAL showed biological safety and was assessed as an efficient hemostatic product with non-inferiority to Celox (its predicate device). It does not generate heat, does not cause systemic clot formation (reacts locally at the wound site only), and does not trigger shellfish allergies (allergens are removed during chitosan purification).
SEAL PRO excels in scenarios where traditional wound packing is difficult or time-consuming: irregular wounds, shrapnel injuries, graze wounds, neck wounds (where packing is contraindicated), multiple simultaneous casualties, and wounds that are difficult to access or pack under fire. It is particularly valuable as an initial intervention — spray to establish a physical barrier, apply pressure, then proceed with standard TCCC hemorrhage control protocols. SEAL can be used in conjunction with QuikClot Combat Gauze and other hemostatic gauze products — these are complementary tools, not mutually exclusive.
How to Use
- Shake the can before use.
- Hold the can 6–10 inches from the wound surface.
- Spray directly onto the bleeding wound for approximately 5 seconds.
- Apply direct pressure over the sprayed area while the chitosan barrier forms (approximately 30 seconds).
- Secure with a pressure bandage.
- For deeper wounds requiring packing, apply SEAL first to establish a surface barrier, then pack with hemostatic gauze — the packing action drives the spray deeper into the wound track.
- Remove with saline rinse at definitive care.
Where SEAL Fits in the Kit
SEAL does not replace tourniquets, wound packing, or pressure dressings — standard TCCC hemorrhage control still applies. Think of SEAL as a rapid-deployment initial intervention that buys time to apply additional interventions. It is not a primary treatment for deep cavitary wounds, junctional hemorrhage, or wounds requiring direct digital pressure to the bleeding vessel. For those applications, hemostatic gauze and tourniquets remain the standard. SEAL's unique advantage is speed and accessibility — wounds that would take 30+ seconds to pack can have a hemostatic barrier established in under 5 seconds.
See MED-TAC's full hemostatic agents collection, or build a complete system with our massive hemorrhage control and IFAK kits.
All products sourced from the actual brand manufacturer or authorized master distributors. CoTCCC recommendation status verified where applicable. Ships from MED-TAC International, Pembroke Pines, FL — clinician-founded, veteran-led, SDVOSB-certified.
Why SEAL PRO
The Tourniquet Gap Solution
Tourniquets can't stop junctional or torso bleeding. SEAL PRO fills the gap — an aerosol hemostatic that works where tourniquets can't reach.
Under 5 Seconds
Empty the can in under 5 seconds. Forms a clot barrier almost instantly — no winding, twisting, or packing required.
FDA-Cleared Chitosan
The only aerosol chitosan hemostatic with FDA 510(k) clearance. Muco-adhesive mechanism forms a physical barrier over wounds.
Junctional & Torso
Works on wounds where tourniquets physically can't be applied — groin, armpit, neck, abdomen. The aerosol reaches where you can't pack.
Extreme Conditions
MIL-STD-810H certified. Functions from -31°F to 160°F. Tested at 40,000 feet altitude. Deploys reliably when you need it most.
Trusted By
Video Library
SEAL PRO Training & Demonstration Videos
Watch real demonstrations, training scenarios, and deployment footage showcasing the first and only FDA-cleared chitosan aerosol hemostatic spray.
Clinical Documentation
Research & Resources
Download clinical studies, testing data, and technical documentation on SEAL Hemostatic Spray technology.
SEAL Testing Summary
Comprehensive overview of clinical testing results and efficacy data across multiple wound models.
Environmental Testing Report
Temperature, altitude, and immersion testing results demonstrating SEAL's extreme condition performance.
Battlefield Hemorrhage Control Lessons
Critical Care Nursing article on hemostatic agents applied in hospital settings (January 2019).
Hemostasis in Orthopedic Oncology Surgery
Study on hemostatic gauze applications in complex surgical procedures.
In Vitro Evaluation of Hemostatic Agents
Summary report on viscoelastic and coagulation properties of topical hemostatic agents.
Novel Contactless Technology Study
Complete research paper on nondestructive evaluation of hemostatic agent properties.
Regulatory Compliance and Certifications
SEAL PRO operates in temperatures from -31F to 160F and altitudes up to 40,000 feet. Tested for extreme environmental conditions.
Need additional clinical data or study details?
Contact MED-TAC International